Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126361232 | 12636123 | 2 | F | 20160804 | 20160809 | 20160817 | EXP | DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-121752 | RANBAXY | VERJANS E, FRANZEN S, VAEBEN P, SCHRADING S, BERLIEN HP, HEIMANN K ET AL. CONGENITAL KAPOSIFORM HEMANGIOENDOTHELIOMA AS HINDRANCE TO BIRTH AND POSTNATAL EMERGENCY. MULTIMODAL TREATMENT CONCEPT. PEDIATRICS MONTHLY LETTER. 2016;164:318-322 | 0.00 | N | F | Y | 0.00000 | 20160817 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126361232 | 12636123 | 1 | PS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Unknown | U | 70321 | ||||||||||
| 126361232 | 12636123 | 2 | SS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | U | 70321 | |||||||||||
| 126361232 | 12636123 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 5 MG/KG, DAILY | U | 0 | 5 | MG/KG | |||||||
| 126361232 | 12636123 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | U | 0 | |||||||||||
| 126361232 | 12636123 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 1 MG/KG, DAILY | 0 | 1 | MG/KG | ||||||||
| 126361232 | 12636123 | 6 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 0 | ||||||||||||
| 126361232 | 12636123 | 7 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 5 MG/KG, DAILY | U | U | 0 | 5 | MG/KG | ||||||
| 126361232 | 12636123 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | U | U | 0 | ||||||||||
| 126361232 | 12636123 | 9 | SS | SIROLIMUS. | SIROLIMUS | 1 | Unknown | 0.1 MG/KG, DAILY | U | 0 | .1 | MG/KG | |||||||
| 126361232 | 12636123 | 10 | SS | SIROLIMUS. | SIROLIMUS | 1 | U | 0 | |||||||||||
| 126361232 | 12636123 | 11 | C | Acetylsalicylic acid | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 126361232 | 12636123 | 12 | C | Acetylsalicylic acid | ASPIRIN | 1 | U | 0 | |||||||||||
| 126361232 | 12636123 | 13 | C | Vincristine | VINCRISTINE | 1 | Unknown | 0.05 MG/KG | U | 0 | |||||||||
| 126361232 | 12636123 | 14 | C | Vincristine | VINCRISTINE | 1 | Unknown | 2 MG/KG, DAILY | U | 0 | 2 | MG/KG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126361232 | 12636123 | 1 | Angiosarcoma |
| 126361232 | 12636123 | 2 | Haemangioma-thrombocytopenia syndrome |
| 126361232 | 12636123 | 3 | Angiosarcoma |
| 126361232 | 12636123 | 4 | Haemangioma-thrombocytopenia syndrome |
| 126361232 | 12636123 | 5 | Angiosarcoma |
| 126361232 | 12636123 | 6 | Haemangioma-thrombocytopenia syndrome |
| 126361232 | 12636123 | 7 | Angiosarcoma |
| 126361232 | 12636123 | 8 | Haemangioma-thrombocytopenia syndrome |
| 126361232 | 12636123 | 9 | Angiosarcoma |
| 126361232 | 12636123 | 10 | Haemangioma-thrombocytopenia syndrome |
| 126361232 | 12636123 | 11 | Thrombosis |
| 126361232 | 12636123 | 12 | Haemangioma-thrombocytopenia syndrome |
| 126361232 | 12636123 | 13 | Angiosarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126361232 | 12636123 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126361232 | 12636123 | Conjunctivitis | |
| 126361232 | 12636123 | Drug ineffective | |
| 126361232 | 12636123 | Hypertension | |
| 126361232 | 12636123 | Impetigo | |
| 126361232 | 12636123 | Pyelonephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |